Skip to content

Contact +44 (0) 20 7060 7474 email us

Ukraine

Ukraine Pharma - New Opportunities for Growth

 

Publication Date November 2008
Publisher RNCOS
Product Type Report
Pages 60
ISBN Number not applicable
Product Code RCS00305

Price

£530.00
approximately: $796 | €581

pdf

Buy Now

print £600 ($902 | €658)

Buy Now

cdrom £600 ($902 | €658)

Buy Now

Order above formats by FAX

Order by Fax

Summary

According to Ukraine Pharma - New Opportunities for Growth, a new research report by RNCOS, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.

The future outlook of the industry also seems very positive as the market is expected to be driven by a number of reforms recently proposed by the government. Factors such as increasing penetration of health insurance and increasing disposable incomes of consumers will also fuel growth. The lack of effective price controls and high margins are also expected to lure foreign players in this market. The countrys unstable political environment, however, will be the biggest hurdle for investments. But overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012.

This report gives an extensive and objective analysis on the pharmaceutical market of Ukraine. It investigates both the past and present trends in the market, with its main focus on the future trends shaping the industry. The study discusses the performance of both the retail and hospital segments of the pharmaceutical market in detail and based on various present and future indicators, analyzes the future of these segments. This report gives valuable information to manufacturers/investors planning to enter the Ukrainian pharmaceutical market.

The Report Provides Forecasts on

  • Macroeconomic Indicators
  • Healthcare Indicators
  • Population & Demographics
  • Disease Profiles
  • Total Pharmaceutical Market
  • Retail Pharmaceutical Market
  • Hospital Pharmaceutical Market

Key Player Profiling

Ukraine Pharma - New Opportunities for Growth provides brief profiling on key players, both domestic and foreign, currently operating in the Ukraine pharmaceutical market. This section describes the revenues and growth of players in the total pharmaceutical market, retail market and hospital market. Performance of key drugs in various segments of the market has also been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this report.

Contents

  • 1. Analyst View
  • 2. What Makes Ukraine so Lucrative
    • 2.1 Robust Economic Growth
    • 2.2 Improved Investment Climate
    • 2.3 Growth of High-priced Drugs
    • 2.4 Healthcare Infrastructure
  • 3. Population & Demographics
  • 4. The Pharmaceutical Market
    • 4.1 Market Size
    • 4.2 Imported & Domestically Manufactured Drugs
    • 4.3 Leading Domestic & Foreign Manufacturers
    • 4.4 Leading Pharmaceutical Distributors
  • 5. The Retail Market
    • 5.1 Market Size
    • 5.2 Prescription & OTC Sales
    • 5.3 Therapeutic Segmentation
    • 5.4 Leading Domestic & Foreign Players
    • 5.5 Leading Drugs
    • 5.6 Price Characteristics of Drug Consumption
  • 6. The Hospital Market
    • 6.1 Market Size
    • 6.2 Prescription & OTC Sales
    • 6.3 Therapeutic Segmentation
    • 6.4 Leading Domestic & Foreign Players
    • 6.5 Leading Drugs
    • 6.6 Price Characteristics of Drug Consumption
  • 7. Opportunities
    • 7.1 Clinical Trials Market
    • 7.2 Contract Manufacturing
    • 7.3 Medical Devices Market
  • 8. Roadblocks
    • 8.1 Unstable Political Environment
    • 8.2 Declining Population
    • 8.3 Lack of Effective Reimbursement System
    • 8.4 Opaque Tax System
  • 9. Forecasts
    • 9.1 Critical Success & Risk Factors Shaping the Future
      • 9.1.1 Critical Success Factors
      • 9.1.2 Critical Risk Factors
    • 9.2 Pharmaceutical Market
      • 9.2.1 Retail Market
      • 9.2.2 Hospital Market
  • 10. Key Company Profiles
    • 10.1 Berlin-Chemie
    • 10.2 Sanofi-Aventis Group
    • 10.3 Novartis
    • 10.4 Arterium
    • 10.5 Darnitsa Pharma
  • List of Figures:
    • Figure 2-1: Ukraine - Nominal GDP (in Billion US$), 2001-2007 & 2012F
    • Figure 2-2: Ukraine - Disposable Income per Head (in US$), 2001-2007E & 2012F
    • Figure 2-3: Ukraine - Healthcare Expenditure per Head (in US$), 2001-2007E & 2012F
    • Figure 2-4: Ukraine - Hospital Beds (per 000 Population), 2001-2007E & 2012F
    • Figure 2-5: Ukraine - Doctors (per 000 Population), 2002-2007E & 2012F
    • Figure 3-1: Ukraine - Population (in Million), 2001-2007E & 2012F
    • Figure 3-2: Ukraine - Population Breakup by Age Group (%), 2005-2007E & 2012F
    • Figure 3-3: Ukraine - Leading Causes of Death (%), 2005
    • Figure 3-4: Ukraine - Deaths due to Leading Causes (in Number), 2005
    • Figure 3-5: Ukraine - Forecast for Leading Causes of Death (%), 2030
    • Figure 3-6: US - Forecast for Deaths due to Leading Causes (in Number), 2030
    • Figure 4-1: Ukraine - Pharmaceutical Market (in Million US$), 2006 & 2007
    • Figure 4-2: Ukraine - Pharmaceutical Market (in Million Units), 2006 & 2007
    • Figure 4-3: Ukraine - Proportion of Generic & Branded Drugs (%)
    • Figure 4-4: Ukraine - Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Value (%), 2006 & 2007
    • Figure 4-5: Ukraine - Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Volume (%), 2006 & 2007
    • Figure 4-6: Ukarine - Pharmaceutical Imports (in Billion US$), 2005-2007E
    • Figure 4-7: Ukarine - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market by Sales Value (%), 2006 & 2007E
    • Figure 4-8: Ukarine - Top 5 Pharmaceutical Importing Countries (in 000 Units) 2006 & 2007
    • Figure 5-1: Ukraine - Retail Pharmaceutical Market (in Million US$), 2006 & 2007
    • Figure 5-2: Ukraine - Retail Pharmaceutical Market (in Million Units), 2006 & 2007
    • Figure 5-3: Ukraine - Share of RX & OTC Drugs in Retail Pharmaceutical Market by Sales Value (%), 2006 & 2007
    • Figure 5-4: Ukraine - Share of RX & OTC Drugs in Retail Pharmaceutical Market by Sales Volume (%), 2006 & 2007
    • Figure 5-5: Ukraine - Retail Pharmaceutical Market by Therapeutic Area (%), 2007
    • Figure 6-1: Ukraine - Hospital Pharmaceutical Market (in Million US$), 2006 & 2007
    • Figure 6-2: Ukraine - Hospital Pharmaceutical Market (in Million Units), 2006 & 2007
    • Figure 6-3: Ukraine - Share of RX & OTC Drugs in Hospital Pharmaceutical Market by Sales Value (%), Q1-Q3 2007
    • Figure 6-4: Ukraine - Share of RX & OTC Drugs in Hospital Pharmaceutical Market by Sales Volume (%), Q1-Q3 2007
    • Figure 6-5: Ukraine - Hospital Pharmaceutical-Market by Therapeutic Area (%), Q1-Q3 2007
    • Figure 7-1: Ukraine - Medical Devices Market (in Million US$), 2007E & 2012F
    • Figure 9-1: Ukraine - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
    • Figure 9-2: Ukraine - Forecast for Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Value (%), 2008-2012
    • Figure 9-3: Ukraine - Forecast for Retail Pharmaceutical Market (in Million US$), 2008-2012
    • Figure 9-4: Ukraine - Forecast for Hospital Pharmaceutical Market (in Million US$), 2008-2012
  • List of Tables:
    • Table 2-1: Ukraine - Average Price per Trading Unit of Pharmaceuticals (in US$), 2006 & 2007
    • Table 2-2: Ukraine - Hospital Beds & Doctors w.r.t. Developed Countries (per 000 Population), 2007E
    • Table 4-1: Ukraine - Statistics of Top Players in Pharmaceutical Market (2007)
    • Table 4-2: Ukraine - Market Share of Top Pharmaceutical Distributors (%), 2006 & 2007
    • Table 5-1: Ukraine - Statistics of Top Players in Retail Pharmaceutical Market (2007)
    • Table 5-2: Ukraine - Statistics of Top 10 Drugs in Retail Pharmaceutical Market (2007)
    • Table 5-3: Ukraine - Price Characteristics of Drug Consumption in Retail Pharmaceutical Market
    • Table 6-1: Ukraine - Statistics of Top Players in Hospital Pharmaceutical Market (2007)
    • Table 6-2: Ukraine - Statistics of Top 20 Drugs in Hospital Pharmaceutical Market (Q1-Q3 2007)
    • Table 6-3: Ukraine - Average Retail Price per Drug in Hospital Pharmaceutical Market (in US$), Q1-Q3 2006 & Q1-Q3 2007
    • Table 9-1: Ukraine - Critical Sucess Factors for Pharmaceutical Market
    • Table 9-2: Ukraine - Critical Risk Factors for Pharmaceutical Market